Northwestern Mutual Wealth Management’s Bicara Therapeutics BCAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-157
Closed -$4.66K – 4496
2026
Q2
$4.66K Hold
157
– – ﹤0.01% 3403
2026
Q1
$3.12K Buy
+157
New +$2.7K ﹤0.01% 3461

Other funds holding BCAX

Northwestern Mutual Wealth Management's BCAX Position: Q3 2026 in Review

Northwestern Mutual Wealth Management sold out of Bicara Therapeutics (BCAX) in Q3 2026, closing a stake of 157 shares — an estimated $4.66K sold.

Northwestern Mutual Wealth Management first reported a position in BCAX in Q1 2026 and held it in 2 quarters. The position peaked at $4.66K in Q2 2026. 169 funds tracked by Wall St. Rank hold BCAX as of Q3 2026.

  • Northwestern Mutual Wealth Management reported no remaining Bicara Therapeutics position as of Q3 2026 after selling out during the quarter.
  • Northwestern Mutual Wealth Management sold 157 Bicara Therapeutics shares in Q3 2026, an estimated $4.66K.
  • Northwestern Mutual Wealth Management first reported a position in Bicara Therapeutics in Q1 2026 and held it in 2 quarters.
  • Northwestern Mutual Wealth Management's Bicara Therapeutics position peaked at $4.66K in Q2 2026.
  • 169 funds tracked by Wall St. Rank held Bicara Therapeutics as of Q3 2026.

Based on Northwestern Mutual Wealth Management's 13F filing for Q3 2026, filed 13 Nov 2026.